Mn Pharms

MnPharms is a biotechnology company specializing in molecular farming, a process that uses plants as bioreactors to produce recombinant proteins. By utilizing a proprietary transient expression system in Nicotiana benthamiana, the company can produce complex proteins such as growth factors, enzymes, and antibodies more rapidly and cost-effectively than traditional cell-culture methods. MnPharms operates as both a contract manufacturer and a developer of its own line of high-purity proteins for research and diagnostic applications. Their "Seed to Protein" platform is designed for high scalability and the production of proteins that are often challenging to express in bacterial or mammalian systems. The company aims to streamline the biomanufacturing process, offering a timeline of approximately five weeks from gene sequence to purified product.